Molecular mechanism of 17-allylamino-17-demethoxygeldanamycin (17-AAG)-induced AXL receptor tyrosine kinase degradation.
about
AXL kinase as a novel target for cancer therapyProtein homeostasis at the plasma membraneA Decade of Boon or Burden: What Has the CHIP Ever Done for Cellular Protein Quality Control Mechanism Implicated in Neurodegeneration and Aging?AUY922 effectively overcomes MET- and AXL-mediated resistance to EGFR-TKI in lung cancer cellsHsp90-Associated Immunophilin Homolog Cpr7 Is Required for the Mitotic Stability of [URE3] Prion in Saccharomyces cerevisiae.Regulated intramembrane proteolysis of the AXL receptor kinase generates an intracellular domain that localizes in the nucleus of cancer cells.Cks1 proteasomal degradation is induced by inhibiting Hsp90-mediated chaperoning in cancer cells.ALK inhibitor resistance in ALK(F1174L)-driven neuroblastoma is associated with AXL activation and induction of EMT.MicroPET/CT Imaging of AXL Downregulation by HSP90 Inhibition in Triple-Negative Breast Cancer.Chaperone-Mediated Regulation of Choline Acetyltransferase Protein Stability and Activity by HSC/HSP70, HSP90, and p97/VCP.Novel strategy for a bispecific antibody: induction of dual target internalization and degradation.Violacein induces death of RAS-mutated metastatic melanoma by impairing autophagy process.Overcoming drug-tolerant cancer cell subpopulations showing AXL activation and epithelial-mesenchymal transition is critical in conquering ALK-positive lung cancer.
P2860
Q26863442-7969F3D4-4640-48E9-ADCC-1E333B6D2714Q27009009-CCDBF016-03B6-4B53-825E-7F63E823477CQ28078724-7BC6E3E4-F3ED-4679-BD0C-1E1BA050D9CDQ35188254-8CE8AF84-8062-4244-8E91-0B749E5BDEE5Q35810283-E9F116A7-007D-4725-9A5E-BE698922D8CBQ37699039-FED8FBB6-D896-4DC9-AA5C-2AFE9978ED3EQ38925021-7E7DD7B4-8D9F-4DE9-806F-41A2A21087D7Q42572358-98C0E95A-5263-4A99-9788-A52FD7E72064Q43246838-B8B9DB10-DBFF-484B-8092-2E9C9E6A5071Q47222331-85C1BCA3-4905-437E-9E37-9A8C8EC0675BQ50882714-31BE13A8-9730-453B-9D81-8125C9762B0AQ51584417-DA1FC71B-6507-431A-BC3F-9E96A2AE22EEQ55280343-42A7FBD0-8DF3-4A8B-82F3-A28379BB50D1
P2860
Molecular mechanism of 17-allylamino-17-demethoxygeldanamycin (17-AAG)-induced AXL receptor tyrosine kinase degradation.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Molecular mechanism of 17-ally ...... r tyrosine kinase degradation.
@en
Molecular mechanism of 17-allylamino-17-demethoxygeldanamycin
@nl
type
label
Molecular mechanism of 17-ally ...... r tyrosine kinase degradation.
@en
Molecular mechanism of 17-allylamino-17-demethoxygeldanamycin
@nl
prefLabel
Molecular mechanism of 17-ally ...... r tyrosine kinase degradation.
@en
Molecular mechanism of 17-allylamino-17-demethoxygeldanamycin
@nl
P2093
P2860
P356
P1476
Molecular mechanism of 17-ally ...... r tyrosine kinase degradation.
@en
P2093
Elvira Avilla
Francesca Carlomagno
Gnana Prakasam Krishnamoorthy
Massimo Santoro
Rosa Marina Melillo
Teresa Guida
P2860
P304
17481-17494
P356
10.1074/JBC.M112.439422
P407
P50
P577
2013-04-29T00:00:00Z